GINA BUTTNER: Open Payments
NPI 1225784770 · SLIDELL, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,298 in 71 payments from 19 companies in 2025. Trend: 2023 $1,349 · 2024 $1,384 · 2025 $1,298
Food & beverage: $1,298
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $282 |
| Novo Nordisk Inc | 12 | $205 |
| GlaxoSmithKline, LLC. | 8 | $150 |
| Lilly USA, LLC | 8 | $120 |
| Exact Sciences Corporation | 5 | $97 |
| Axsome Therapeutics, Inc. | 3 | $72 |
| PFIZER INC. | 3 | $50 |
| Phathom Pharmaceuticals, Inc. | 3 | $46 |
| Eisai Inc. | 2 | $43 |
| ABBVIE INC. | 2 | $42 |
Products named: BREZTRI, SHINGRIX, Ozempic, MOUNJARO, FARXIGA, Auvelity, Cologuard Collection Kit, Rybelsus.
Industry payments across LA — which companies pay providers there.
